Radiation Oncology Treatment
Approximately 50% of cancer patients who undergo cancer therapy are subjected to radiation therapy at some point of the treatment plan. Radiation treatment is largely a local therapy in which radiation is administered in and around the cancer cells, and hence accuracy in radiation oncology is pivotal to determine its effectiveness. Cytecare Radiation Oncology Centre has therefore been set up with the most advanced technology like the Elekta Versa HD, the first such machine in Karnataka. The technology is administered by a fully trained and skillful team comprising of radiation oncologist, radiology and imaging specialists, physicists and dosimetrists who undertake an extensive treatment planning approach in close consultation with the multidisciplinary team of surgical and medical oncologists.
At Cytecare, to administer personalised care to all its patients, the multidisciplinary team of experts devise the dosage, the pattern of administration and the implications of the therapy on the overall well-being of the patient. Radiation therapy is included in the patient's individualised treatment plan as the primary form of treatment, combined with other treatments like chemotherapy to fight against the growth of new cancer cells, before surgery to shrink a tumour, after surgery to eliminate any remaining cancer cells, as a treatment for cancer that has spread to other areas of the body or as a palliative treatment to relieve pain.
Services
- 3D Conformal radiation therapy
- Intensity modulated Radio Therapy (IMRT)
- Sequential
- Simultaneous Integrated boost technique (SIB)
- Volume modulated arc therapy (VMAT)
- Stereotactic Radiosurgery (SRS)
- Stereotactic Body Radiation Therapy (SBRT)
CAR-T Cell Therapy Procedure
- T-Cell Collection: The CAR-T Cell Therapy procedure begins with collecting T-Cells from the patient's blood. This process, known as leukapheresis, involves removing blood from the patient's body through a needle or catheter. The blood is then passed through a machine that separates the T-Cells from the other components. The remaining blood components are returned to the patient's body while the isolated T-Cells are collected for further processing.
- T-Cell Engineering: Once the T-Cells have been collected, they are sent to the laboratory where they are genetically modified. Scientists introduce a synthetic gene into the T-Cells, enabling them to express a chimeric antigen receptor (CAR) on their surface. This receptor is designed to recognize and bind to a specific antigen present on the cancer cells.
- T-Cell Expansion: After the T-Cells have been genetically modified, they undergo a period of cell culture and expansion. This step involves providing the T-Cells with the necessary growth factors and nutrients to multiply and increase in number. This ensures that a significant amount of CAR-expressing T-Cells are available for treatment.
- CAR-T Cell Infusion: Once a sufficient number of CAR-expressing T-Cells have been produced, they are infused back into the patient's bloodstream. This process is similar to a blood transfusion and is typically administered in a hospital setting. The infused CAR-T Cells then circulate within the patient's body, seeking out and attacking the cancer cells that express the specific antigen recognised by the CAR.
Our Hospital holds highest ratings on Google
